Zimmer Biomet Resolves Anti-Bribery Matters with DOJ and SEC

Zimmer Biomet (ZBH) paid an aggregate ~$30.5MM settlement and concluded agreements with the U.S. Department of Justice (DOJ) and U.S. Securities and Exchange Commission (SEC) regarding previously-disclosed U.S. Foreign Corrupt Practices Act (FCPA) matters involving Biomet, as well as matters relating to the former Deferred Prosecution Agreement...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us